Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
5,560 INR | +1.54% | +0.05% | +0.14% |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
- The company presents an interesting fundamental situation from a short-term investment perspective.
Strengths
- The company returns high margins, thereby supporting business profitability.
- The company is in a robust financial situation considering its net cash and margin position.
- For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
- Historically, the company has been releasing figures that are above expectations.
Weaknesses
- The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 29.61 times its estimated earnings per share for the ongoing year.
- With an enterprise value anticipated at 4.33 times the sales for the current fiscal year, the company turns out to be overvalued.
- In relation to the value of its tangible assets, the company's valuation appears relatively high.
- The company is highly valued given the cash flows generated by its activity.
- For the last four months, the sales outlook for the coming years has been revised downwards. No recovery of the group's activities is yet foreseen.
Ratings chart - Surperformance
Sector: Agricultural Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+0.14% | 2.93B | - | ||
+15.82% | 38.79B | C | ||
-.--% | 10.98B | - | B+ | |
-4.50% | 7.52B | A | ||
+4.44% | 6.81B | B- | ||
-3.63% | 6B | B+ | ||
-10.52% | 5.59B | - | C- | |
-3.77% | 5.66B | B | ||
+33.14% | 5.26B | B- | ||
-12.64% | 4.56B | C+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
- Stock Market
- Equities
- BAYERCROP Stock
- BAYERCROP Stock
- Ratings Bayer CropScience Limited